Depo-Provera is a birth control shot that is injected every three months and features a type of progestin hormone called ...

A new study allegedly discovered that women using a specific form of birth control had a "significantly higher risk" of ...

On Thursday in Washington, D.C., the U.S. Food and Drug Administration (FDA) convened a panel of top experts to reassess the ...

The hormonal treatments cyproterone acetate and medroxyprogesterone acetate are the most effective at reducing hot flushes, a common side-effect in men being treated with hormone therapy for ...

Use of the injectable contraceptive depot medroxyprogesterone acetate (MPA), common in areas such as sub-Saharan Africa with high HIV-1 prevalence, is associated with suppression of the immune ...

The medroxyprogesterone acetate first came into use in 1958 and is on the list of World Health Organisation's list prestigious list of Essential Medicines, a list of safe and effective medicines.

A new study has linked a type of injectable birth control with meningioma. The manufacturer says the claims are “without ...

Sixty patients were entered (thalidomide:medroxyprogesterone = 29:31; median age, 59 [thalidomide], 60 [medroxyprogesterone]; No. of patients assessable for response, 22 [thalidomide], 26 ...

Send press releases and comments to [email protected]. Cite this: Depot Medroxyprogesterone Acetate Associated With Fracture Risk in Young Women - Medscape - Sep 16, 2009.

Men with prostate cancer who reported having significant hot flushes during androgen suppression treatment had a better hormonal response with cyproterone and medroxyprogesterone compared with ...

Nearly half of women using depot medroxyprogesterone acetate (DMPA), commonly known as the birth control shot, will experience high bone mineral density (BMD) loss in the hip or lower spine within ...